Home ›
Trademark Categories ›
Pharmaceuticals ›
2019 ›
BE ›
BEVLUMA
Trademark search for:
BEVLUMA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2019-06-06 — Application filed
2019-06-10 — Application filed
2019-06-20 — Application filed
2019-08-08 — Attorney/dom.rep.revoked and/or appointed
2019-08-08 — Teas revoke/app/change addr of atty/dom rep received
2019-08-28 — Assigned to examiner
2019-09-03 — Final disposition recorded
2019-09-03 — Final disposition recorded
2019-09-03 — Final disposition recorded
2020-03-02 — Office action issued
2020-03-02 — Correspondence received in law office
2020-03-03 — Teas/email correspondence entered
2020-03-25 — Suspension letter written
2020-03-25 — Letter of suspension e-mailed
2020-03-25 — Notification of letter of suspension e-mailed
2020-11-05 — Assigned to lie
2020-11-10 — Suspension inquiry written
2020-11-10 — Inquiry to suspension e-mailed
2020-11-10 — Notification of inquiry as to suspension e-mailed
2020-11-10 — Suspension checked - to attorney for action
2020-11-24 — Teas response to suspension inquiry received
2020-11-24 — Correspondence received in law office
2020-11-25 — Teas/email correspondence entered
2020-12-10 — Approved for pub - principal register
2020-12-11 — On hold - electronic record review required
2020-12-14 — Electronic record review complete
2020-12-30 — Notification of notice of publication e-mailed
2021-01-19 — Published for opposition
2021-01-19 — Official gazette publication confirmation e-mailed
2021-03-16 — Noa e-mailed - sou required from applicant
2021-07-22 — Attorney/dom.rep.revoked and/or appointed
2021-07-22 — Teas change of domestic representatives address
2021-07-22 — Teas change of correspondence received
2021-07-22 — Teas revoke/app/change addr of atty/dom rep received
2021-10-18 — Application abandoned
2021-10-18 — Application abandoned
2021-10-18 — Final status recorded
Owner Information
Centus Biotherapeutics Limited
Centus Biotherapeutics Limited
Correspondent
Cara M. Kearney AstraZeneca Pharmaceuticals LP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
